Progress in Prevention and Treatment of Acute Bone Loss in Orthopedics

被引:0
作者
Wang, Haoran [1 ]
Wu, Ji [2 ]
Wang, Boyao [1 ]
Qin, Hu [1 ]
Fan, Lei [1 ]
Wang, Yunhua [1 ]
He, Bin [1 ]
机构
[1] Nanjing Med Univ, Dept Orthopaed, Affiliated Hosp 2, Nanjing, Peoples R China
[2] Nanjing Med Univ, Sir Run Run Hosp, Dept Orthopaed, Nanjing, Peoples R China
关键词
TOTAL HIP-ARTHROPLASTY; BIOCHEMICAL MARKERS; SUBSEQUENT HIP; OSTEOPOROSIS; FRACTURE; OSTEOCLASTS; MANAGEMENT; CALCITONIN; TURNOVER; ESTROGEN;
D O I
10.1155/2023/9373043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Orthopedic patients need to perform limb immobilization for several days to several weeks due to fracture or other special circumstances. When the function of a certain part or the whole body is restricted, the activity of osteoclasts will be enhanced and its life activity will surpass that of osteoblasts, so local or even whole body bone loss will occur. Acute bone loss usually occurs within a few weeks after the immobilization of limbs. At this stage, the patient's bone mass will decrease sharply, and the patient is prone to osteoporotic refracture. After that, the bone mass will gradually recover, but the speed of bone formation and bone absorption is difficult to reach a balanced state, and the bone mass of patients will continue to decline after it has recovered to a certain degree. After acute progressive bone loss, a large number of bones were lost and the strength of bones decreased. It is often difficult to recover to the level before fracture for a long time, which undoubtedly increases the risk of osteoporosis and related refractures. According to this common phenomenon of bone loss, clinical treatment varies greatly. After a series of research and practice, clinicians summed up some rules and put forward some feasible suggestions, thus strengthening clinicians' understanding of the treatment of acute bone loss, effectively improving the treatment effect of acute bone loss, having far-reaching significance for preventing and treating osteoporosis, reducing the risk of fracture, and improving the long-term prognosis of patients.
引用
收藏
页数:10
相关论文
共 75 条
  • [1] Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies
    Abu-Amer, Yousef
    Darwech, Isra
    Clohisy, John C.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2007, 9 (Suppl 1)
  • [2] Pathophysiology of bone loss in disuse osteoporosis
    Alexandre, Christian
    Vico, Laurence
    [J]. JOINT BONE SPINE, 2011, 78 (06) : 572 - 576
  • [3] Current methods of preventing aseptic loosening and improving osseointegration of titanium implants in cementless total hip arthroplasty: a review
    Apostu, Dragos
    Lucaciu, Ondine
    Berce, Cristian
    Lucaciu, Dan
    Cosma, Dan
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2018, 46 (06) : 2104 - 2119
  • [4] Changes of the biochemical markers of bone turnover and periprosthetic bone remodeling after cemented hip arthroplasty
    Arabmotlagh, M
    Sabljic, R
    Rittmeister, M
    [J]. JOURNAL OF ARTHROPLASTY, 2006, 21 (01) : 129 - 134
  • [5] Pathophysiology of Osteoporosis New Mechanistic Insights
    Armas, Laura A. G.
    Recker, Robert R.
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2012, 41 (03) : 475 - +
  • [6] Romosozumab for the treatment of osteoporosis
    Bandeira, Leonardo
    Lewiecki, E. Michael
    Bilezikian, John P.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (02) : 255 - 263
  • [7] Management of Acute Hip Fracture
    Bhandari, Mohit
    Swiontkowski, Marc
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (21) : 2053 - 2062
  • [8] IL-6, IL-1β, and TNF-α only in combination influence the osteoporotic phenotype in Crohn's patients via bone formation and bone resorption
    Blaschke, Martina
    Koepp, Regine
    Cortis, Julia
    Komrakova, Marina
    Schieker, Matthias
    Hempel, Ute
    Siggelkow, Heide
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 27 (01): : 45 - 56
  • [9] Teriparatide A Review of its Use in Osteoporosis
    Blick, Stephanie K. A.
    Dhillon, Sohita
    Keam, Susan J.
    [J]. DRUGS, 2008, 68 (18) : 2709 - 2737
  • [10] Biochemical markers for assessment of calcium economy and bone metabolism: application in clinical trials from pharmaceutical agents to nutritional products
    Bonjour, Jean-Philippe
    Kohrt, Wendy
    Levasseur, Regis
    Warren, Michelle
    Whiting, Susan
    Kraenzlin, Marius
    [J]. NUTRITION RESEARCH REVIEWS, 2014, 27 (02) : 252 - 267